We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Australia Lists New HCV Drugs on National Formulary for $6
Ipsen Scoops Up Exelixis Drug for Up to $855M
FDA Grants BioMarin’s BMN 270 Gene Therapy Orphan Drug Status
Aurinia’s Lupus Treatment Garners Fast Track Status